Protective effect of L-glutamine against diabetes-induced nephropathy in experimental animal: Role of KIM-1, NGAL, TGF-β1, and collagen-1

References

• Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev. 2002;23:599–622.
   PubMed Web of Science ®Google Scholar
• Yorek MA. The role of oxidative stress in diabetic vascular and neural disease. Free Radic. Res. 2003;37:471–480.
   PubMed Web of Science ®Google Scholar
• Atkins RC. The epidemiology of chronic kidney disease. Kidney Int. 2005;67:S14–S18.
   Google Scholar
• Tarchini R, Bottini E, Botti P, et al. [Type 2 diabetic nephropathy: clinical course and prevention proposals 2004]. Giornale Italiano Di Nefrologia: Organo Ufficiale Della Societa Italiana Di Nefrologia. 2004;22:S15–S19.
   Google Scholar
• Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int. 2000;58:S93–S98.
   Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 2005;59:365–373.
   PubMed Web of Science ®Google Scholar
• Ruiz-Munoz L, Vidal-Vanaclocha F, Lampreabe I. Enalaprilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations. Nephrol Dial Transplant. 1997;12:456–464.
   PubMed Web of Science ®Google Scholar
• Hunt JV, Bottoms MA, Mitchinson MJ. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production. Biochem J. 1993;291:529–535.
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res. 1998;37:586–600.
   PubMed Web of Science ®Google Scholar
• Sourris K, Morley A, Koitka A, et al. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. Diabetologia. 2010;53:2442–2451.
   PubMed Web of Science ®Google Scholar
• Yamagishi S-i, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longev. 2010;3:101–108.
   PubMed Web of Science ®Google Scholar
• Gross M, Ritz E, Schoof A, et al. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes. Lab Invest. 2004;84:452–464.
   PubMed Web of Science ®Google Scholar
• Lee SE, Ma W, Rattigan EM, et al. Ultrastructural features of retinal capillary basement membrane thickening in diabetic swine. Ultrastruct Pathol. 2010;34:35–41.
   PubMed Web of Science ®Google Scholar
• Rohrbach D, Wagner C, Star V, Martin G, Brown K, Yoon J-W. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice. J Biol Chem. 1983;258:11672–11677.
   PubMed Web of Science ®Google Scholar
• Ihm C-G, Lee GS, Nast CC, et al. Early increased renal procollagen α1 (IV) mRNA levels in streptozotocin induced diabetes. Kidney Int. 1992;41:768–777.
   PubMed Web of Science ®Google Scholar
• Carpenter L, Cordery D, Biden TJ. Inhibition of protein kinase C δ protects rat INS-1 cells against interleukin-1β and streptozotocin-induced apoptosis. Diabetes. 2002;51:317–324.
   PubMed Web of Science ®Google Scholar
• Bendayan M. Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes. Kidney Int. 1998;54:438–447.
   PubMed Web of Science ®Google Scholar
• Chai J, Sheng Z. [A brief account of prevention and treatment of infection in burn patients]. Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns. 2008;24:84–86.
   PubMedGoogle Scholar
• Gismondo M, Drago L, Fassina M, Vaghi I, Abbiati R, Grossi E. Immunostimulating effect of oral glutamine. Dig Dis Sci. 1998;43:1752–1754.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Bodhankar SL, Singh V, Mohan V, Thakurdesai PA. Anti-asthmatic effects of type-A procyanidine polyphenols from cinnamon bark in ovalbumin-induced airway hyperresponsiveness in laboratory animals. Biomed Aging Pathol. 2013;3:23–30.
   Google Scholar
• Williams MH. Dietary supplements and sports performance: minerals. J Int Soc Sports Nutr. 2005;2:43–49.
   PubMed Web of Science ®Google Scholar
• Garrett AR, Weagel EG, Martinez AD, Heaton M, Robison RA, O’Neill KL. A novel method for predicting antioxidant activity based on amino acid structure. Food Chem. 2014;158:490–496.
   PubMed Web of Science ®Google Scholar
• Trachtman H, Futterweit S, Maesaka J, et al. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol Renal Physiol. 1995;269:F429–F438.
   PubMed Web of Science ®Google Scholar
• Winiarska K, Szymanski K, Gorniak P, Dudziak M, Bryla J. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie. 2009;91:261–270.
   PubMed Web of Science ®Google Scholar
• Manna P, Das J, C Sil P. Role of sulfur containing amino acids as an adjuvant therapy in the prevention of diabetes and its associated complications. Curr Diabetes Rev. 2013;9:237–248.
   PubMedGoogle Scholar
• Todorova VK, Kaufmann Y, Hennings L, Klimberg VS. Oral glutamine protects against acute doxorubicin-induced cardiotoxicity of tumor-bearing rats. J Nutr. 2010;140:44–48.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Saito H, Fukatsu K, et al. Glutamine-enhanced bacterial killing by neutrophils from postoperative patients. Nutrition. 1997;13:863–869.
   PubMed Web of Science ®Google Scholar
• Todorova V, Kaufmann Y, Luo S, Harms S, Babb K, Klimberg V. Glutamine supplementation reduces glutathione levels and stimulates apoptosis in DMBA-induced mammary tumors. J Surg Res. 2003;114:276.
   Google Scholar
• Masuko Y. [Impact of stress response genes induced by L-glutamine on warm ischemia and reperfusion injury in the rat small intestine]. [Hokkaido Igaku Zasshi] Hokkaido J Med Sci. 2002;77:169–183.
   PubMedGoogle Scholar
• de Oliveira Mora L, Antunes LMG, Bianchi MLP. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 2003;47:517–522.
   PubMed Web of Science ®Google Scholar
• Bhatt L, Veeranjaneyulu A. Minocycline with aspirin: A therapeutic approach in the treatment of diabetic neuropathy. Neurol Sci. 2010;31:705–716.
   PubMed Web of Science ®Google Scholar
• Goswami S, Kandhare A, Zanwar AA, et al. Oral l-glutamine administration attenuated cutaneous wound healing in Wistar rats. Int Wound J. 2016;13:116–124.
   PubMed Web of Science ®Google Scholar
• Vaghasiya J, Sheth N, Bhalodia Y, Manek R. Sitagliptin protects renal ischemia reperfusion induced renal damage in diabetes. Regul Pept. 2011;166:48–54.
   PubMedGoogle Scholar
• Kandhare AD, Shivakumar V, Rajmane A, Ghosh P, Bodhankar SL. Evaluation of the neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury. J Nat Med. 2014;68:586–603.
   PubMed Web of Science ®Google Scholar
• Adil M, Visnagri A, Kumar VS, Kandhare AD, Ghosh P, Bodhankar SL. Protective effect of naringin on sodium arsenite induced testicular toxicity via modulation of biochernical perturbations in rxperiinental rats. Pharmacologia. 2014;5:222–234.
   Google Scholar
• Badole SL, Chaudhari SM, Jangam GB, Kandhare AD, Bodhankar SL. Cardioprotective activity of Pongamia pinnata in Streptozotocin-Nicotinamide Induced Diabetic Rats. Biomed Res Int. 2015;2015:403291.
   PubMed Web of Science ®Google Scholar
• Ghule AE, Kandhare AD, Jadhav SS, Zanwar AA, Bodhankar SL. Omega-3-fatty acid adds to the protective effect of flax lignan concentrate in pressure overload-induced myocardial hypertrophy in rats via modulation of oxidative stress and apoptosis. Int Immunopharmacol. 2015;28:751–763.
   PubMed Web of Science ®Google Scholar
• Honmore V, Kandhare A, Zanwar AA, Rojatkar S, Bodhankar S, Natu A. Artemisia pallens alleviates acetaminophen induced toxicity via modulation of endogenous biomarkers. Pharm Biol. 2015;53:571–581.
   PubMed Web of Science ®Google Scholar
• Kamble H, Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of low molecular weight galactomannans from fenugreek seeds on animal models of diabetes mellitus. Biomed Aging Pathol. 2013;3:145–151.
   Google Scholar
• Kandhare AD, Alam J, Patil MV, Sinha A, Bodhankar SL. Wound healing potential of naringin ointment formulation via regulating the expression of inflammatory, apoptotic and growth mediators in experimental rats. Pharm Biol. 2016;54:419–432.
   PubMed Web of Science ®Google Scholar
• Adil M, Kandhare AD, Visnagri A, Bodhankar SL. Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: decisive role of KIM-1, Caspase-3, TGF-β, and TNF-α. Ren Fail. 2015;37:1396–1407.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Prophylactic efficacy and possible mechanisms of oligosaccharides based standardized fenugreek seed extract on high-fat diet-induced insulin resistance in C57BL/6 mice. J App Pharma Sci. 2015;5:035–045.
   Google Scholar
• Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol-induced neuropathic pain. Fundam Clin Pharmacol. 2013;27:603–622.
   PubMed Web of Science ®Google Scholar
• Visnagri A, Kandhare AD, Ghosh P, Bodhankar SL. Endothelin receptor blocker bosentan inhibits hypertensive cardiac fibrosis in pressure overload-induced cardiac hypertrophy in rats. Cardiovasc Endocrinol. 2013;2:85–97.
   Google Scholar
• Visnagri A, Kandhare AD, Bodhankar SL. Renoprotective effect of berberine via intonation on apoptosis and mitochondrial-dependent pathway in renal ischemia reperfusion-induced mutilation. Ren Fail. 2015;37:482–493.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Patil MV, Bodhankar SLL. Arginine attenuates the ethylene glycol induced urolithiasis in ininephrectomized hypertensive rats: role of KIM-1, NGAL, and NOs. Ren Fail. 2015;37:709–721.
   PubMed Web of Science ®Google Scholar
• Collart F. [Kidney failure, proteinuria, and diabetic nephropathy]. Rev Med Brux. 2003;24:A257–A262.
   Google Scholar
• Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia. 2012;83:650–659.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Ghosh P, Bodhankar SL. Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. Chem Biol Interact. 2014;219:101–112.
   PubMed Web of Science ®Google Scholar
• de Oliveira Mora L, Antunes LMG, Francescato HDC, Bianchi MLP. The effects of oral glutamine on cisplatin-induced genotoxicity in Wistar rat bone marrow cells. Mutat Res Gen Toxicol Environ Mutagen. 2002;518:65–70.
   Web of Science ®Google Scholar
• Devkar S, Kandhare A, Zanwar A, et al. Hepatoprotective effect of withanolide rich fraction in acetaminophen intoxicated rat: Decisive role of TNF-α, IL-1β, COX-II, and iNOS. Pharm. Biol. 2016. [Epub ahead of print]. DOI: 10.3109/13880209.2016.1157193.
   PubMedGoogle Scholar
• Budhiraja S, Singh J, Lal H, Arora BR. Renoprotection by telmisartan versus benazepril in streptozotocin induced diabetic nephropathy. Iranian J Pharmacol Ther. 2006;5:135–139.
   Google Scholar
• Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405–412.
   PubMed Web of Science ®Google Scholar
• Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. Suppl. 1995;51:S18–S21.
   Google Scholar
• Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993;16:1433–1437.
   PubMed Web of Science ®Google Scholar
• Ruiz C, Alegria A, Barbera R, Farre R, Lagarda M. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest. 1999;59:99–105.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Therapeutic role of curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett. 2012;511:18–22.
   PubMed Web of Science ®Google Scholar
• Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86:271–278.
   PubMed Web of Science ®Google Scholar
• Kandhare AD, Kumar VS, Adil M, Rajmane AR, Ghosh P, Bodhankar SL. Investigation of gastro protective activity of Xanthium strumarium L. by modulation of cellular and biochemical marker. Orient Pharm Exper Med. 2012;12:287–299.
   Google Scholar
• Kandhare AD, Raygude KS, Shiva Kumar V, et al. Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin-induced diabetic neuropathy in rats. Biomed Aging Pathol. 2012;2:173–186.
   Google Scholar
• Welbourne T. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem. 1979;57:233–237.
   PubMedGoogle Scholar
• Hall J, Heel K, McCauley R. Glutamine. Br J Surg. 1996;83:305–312.
   PubMed Web of Science ®Google Scholar
• Chan GC, Tang SC. Diabetic nephropathy: Landmark clinical trials and tribulations. Nephrol Dial Transplant. 2016;31:359–368.
   PubMed Web of Science ®Google Scholar
• Donate-Correa J, Martín-Núñez E, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF. Inflammatory cytokines in diabetic nephropathy. J Diabet Res. 2015;2015:948417.
   PubMed Web of Science ®Google Scholar
• O’Connor AS, Schelling JR. Diabetes and the kidney. Am J Kidney Dis. 2005;46:766–773.
   PubMed Web of Science ®Google Scholar
• Makino H, Miyamoto Y, Sawai K, et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes. 2006;55:2747–2756.
   PubMed Web of Science ®Google Scholar
• Lan HY. Transforming growth factor-β/Smad signalling in diabetic nephropathy. Clin Exp Pharmacol Physiol.2012;39:731–738.
   PubMed Web of Science ®Google Scholar
• Li L, Yin Q, Tang X, et al. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway. PLoS One. 2014;9:e113639.
   PubMed Web of Science ®Google Scholar
• Shaker O, Sadik N. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy. Human Exp Toxicol. 2013;32:1089–1096.
   PubMed Web of Science ®Google Scholar
• Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension. 1997;29:728–735.
   PubMed Web of Science ®Google Scholar
• Hellmich B, Schellner M, Schatz H, Pfeiffer A. Activation of transforming growth factor-β 1 in diabetic kidney disease. Metabolism. 2000;49:353–359.
   PubMed Web of Science ®Google Scholar
• Kanter M, Sen S, Donmez S, Aktas C, Ustundag S, Erboga M. Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats. Ren Fail. 2010;32:498–505.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ji Y, Lv W, He T, Wang J. Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy. Ren Fail. 2016;38:124–130.
   PubMed Web of Science ®Google Scholar
• Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadillioglu E. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 2004;348:27–34.
   PubMed Web of Science ®Google Scholar
• Sudnikovich EJ, Maksimchik YZ, Zabrodskaya SV, et al. Melatonin attenuates metabolic disorders due to streptozotocin-induced diabetes in rats. Eur J Pharmacol. 2007;569:180–187.
   PubMed Web of Science ®Google Scholar
• Madar Z, Kalet-Litman S, Stark AH. Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats. Pharmacology. 2005;73:106–112.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Schjoedt K, Astrup A, et al. Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril. Diabetic Med. 2010;27:1144–1150.
   PubMed Web of Science ®Google Scholar
• Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425–10432.
   PubMed Web of Science ®Google Scholar
• Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004;15:3073–3082.
   PubMed Web of Science ®Google Scholar
• Ahmed SA, Hamed MA. Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patients. J Diabetes Metab Disord. 2015;14:1.
   PubMedGoogle Scholar
• Alter ML, Kretschmer A, Von Websky K, et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab. 2012;58:659.
   PubMed Web of Science ®Google Scholar
• Attisano L, Wrana JL. Signal transduction by members of the transforming growth factor-beta superfamily. Cytokine Growth Factor Rev.1996;7:327–339.
   PubMedGoogle Scholar
• August P, Suthanthiran M. Transforming growth factor beta signaling, vascular remodeling, and hypertension. N Engl J Med. 2006;354:2721–2723.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Fukui M, Ebihara I, et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 1993;42:450–456.
   PubMed Web of Science ®Google Scholar
• MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest. 1989;83:1160
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci. 1993;90:1814–1818.
   PubMed Web of Science ®Google Scholar
• Ellis D, Forrest KY, Erbey J, Orchard TJ. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: Application in diabetic nephropathy. Clin Chem. 1998;44:950–956.
   PubMed Web of Science ®Google Scholar
• Bertoluci MC, Uebel D, Schmidt A, Thomazelli FCS, Oliveira FR, Schmid H. Urinary TGF-β1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy. Diabetes Res Clin Prac. 2006;72:258–264.
   PubMed Web of Science ®Google Scholar
• Kreisberg JI, Ayo SH. The glomerular mesangium in diabetes mellitus. Kidney Int. 1993;43:109–113.
   PubMed Web of Science ®Google Scholar
• Wang W-S, Lin J-K, Lin T-C, et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist. 2007;12:312–319.
   PubMed Web of Science ®Google Scholar